IL1B and myeloid sarcoma: Of note, such striatal synaptic and behavioral abnormalities were associated with an increased production of the pro-inflammatory cytokine interleukin 1 beta (IL-1β) in the striatum, and the administration of anti-IL-1β therapy was able to improve mood disturbances in mice with experimental MS [200].